NFE2L2 and colorectal carcinoma: As listed, clinical studies of EGCG, curcumin, resveratrol, and genistein have been reported (Table 3), but in CRC, clinical studies have been conducted with only a limited number of phytochemicals and there are no studies related to ROS scavenging and the Nrf2/KEAP1 pathway.